trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['enhertu', 'lung', 'nsclc', 'sclc']
#enhertu in #nsclc
the objective response rate in patients treated with 5.4mg/kg was 53.8%, and 6.4mg/kg was 42.9%. #esmo2022 #esmo #cancer #oncology #cancer #cancerresearch #cancertreatment #cancercare #lungcancer
iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma